# Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.

> **NCT02641158** · NA · COMPLETED · sponsor: **Columbia University** · enrollment: 422 (actual)

## Conditions studied

- Hepatitis C
- HIV
- AIDS
- Substance Use

## Interventions

- **OTHER:** Control Group
- **BEHAVIORAL:** Care Facilitation Group

## Key facts

- **NCT ID:** NCT02641158
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2018-05-09
- **Final completion:** 2018-05-09
- **Target enrollment:** 422 (ACTUAL)
- **Last updated:** 2020-07-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02641158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02641158, "Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02641158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*